IJCM  Vol.7 No.2 , February 2016
Impact of Low Back Pain on Quality of Life: Assessment by Patient Functionality Questionnaire and Treatment Results Using a Combination of Diclofenac plus B Vitamins or Diclofenac Monotherapy
Abstract: Objective: To analyze the Patient Functionality Questionnaire (PFQ) scores of the patients treated with either Diclofenac + B vitamins (Group DB) or Diclofenac monotherapy (Group D) in order to better understand the impact of the combination of diclofenac with vitamins B1, B6, and B12 on quality of life. Research Design/Methods: We performed a post-hoc analysis of tabulated data generated during the DOLOR study (Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study), using the software GraphPad Prism 5 for Windows, v5.04. The absolute number or percentage of “True”/“False” respondents for each questionnaire item at each study visit, together with the absolute number and percentage of subjects with no change, improvement, or worsening of each PFQ item at each study visit, within and between treatment groups were arranged on contingency tables and analyzed with the Chi-squared or Fisher’s Exact test. Results: At pretreatment there were no statistically significant differences between treatment groups (p > 0.05 for all items). At Visit 2 in both treatment groups, there were statistically significant improvements in individual question responses in each of the 12 items of the questionnaire (p < 0.05 for all items). At Visit 2, comparing the distribution of patients in each treatment group with “improvement”, “no change”, or “worsening”, there was a statistically significant superiority among subjects of group DB in response to items 1, 6, 8, and 10. At Visit 3, both groups had statistically significant (p < 0.001) improvements in each individual item of the PFQ in relation to pretreatment values. The distribution of subjects in each treatment group presenting with “improvement”, “no change”, or “worsening” at Visit 3 varied significantly in favor of group DB in the responses to item 4. At Visit 4, the subjects remaining in treatment in both groups showed statistically significant improvement in PFQ responses in relation to pretreatment values (p < 0.05). The distribution of subjects in each treatment group presenting with “improvement” or “no change” at Visit 4 varied significantly in favor of group D in the responses to items 5, 8, and 12. Conclusion: Improvement in overall PFQ scores was observed in both treatment groups, though the specific items of the questionnaire of the subjects in group DB at Visit 2 showed greater improvement in areas related to sleep quality, mobility, ability to wash and dry, ability to walk distances, and posture comfort. These results serve to corroborate the previously published data, which indicates a benefit of combining the B vitamins with diclofenac in the treatment of patients with low back pain, yielding shorter treatment time to resolution of the lumbago in the treated patients.
Cite this paper: Geller, M. , Mibielli, M. , Nunes, C. , Souza da Fonseca, A. , Wrobel Goldberg, S. and Oliveira, L. (2016) Impact of Low Back Pain on Quality of Life: Assessment by Patient Functionality Questionnaire and Treatment Results Using a Combination of Diclofenac plus B Vitamins or Diclofenac Monotherapy. International Journal of Clinical Medicine, 7, 113-119. doi: 10.4236/ijcm.2016.72012.

[1]   Mibielli, M.A., Geller, M., Cohen, J.C., Goldberg, S.G., Cohen, M.T., Nunes, C.P., et al. (2009) Diclofenac plus B Vitamins versus Diclofenac Monotherapy in Lumbago: The DOLOR Study. Current Medical Research and Opinion, 25, 2589-2599.

[2]   Breivik, H., Callett, B., Ventafridda, V., Cohen, R. and Gallacher, D. (2006) Survey of Chronic Pain in Europe: Prevalence, Impact on Daily Life, and Treatment. European Journal of Pain, 10, 287-333.

[3]   Manek, N. and MacGregor, A.J. (2005) Epidemiology of Low Back Disorders. Current Opinion in Rheumatology, 17, 134-140.

[4]   Froud, R., Patterson, S., Eldridge, S., Seale, C., Pincus, T., Rajendran, D., et al. (2014) A Systematic Review and Meta-Synthesis of the Impact of Low Back Pain on People’s Lives. BMC Musculoskeletal Disorders, 15, 50.

[5]   Hart, L.G., Deyo, R.A. and Cherkin, D.C. (1995) Physician Office Visits for Low Back Pain. Frequency, Clinical Evaluation, and Treatment Patterns from a U.S. National Survey. Spine, 20, 11-19.

[6]   Atlas, S.J. and Deyo, R.A. (2001) Evaluating and Managing Acute Low Back Pain in the Primary Care Setting. Journal of General Internal Medicine, 16, 120-131.

[7]   Maetzel, A. and Li, L. (2002) The Economic Burden of Low Back Pain: A Review of Studies Published between 1996 and 2001. Best Practice & Research Clinical Rheumatology, 16, 23-30.

[8]   Kelly, G.A., Blake, C., Power, C.K., O’keeffe, D. and Fullen, B.M. (2011) The Association between Chronic Low Back Pain and Sleep: A Systematic Review. Clinical Journal of Pain, 27, 169-181.

[9]   Perez-Flores, E., Medina-Santillán, R., Reyes-García, G. and Mateos-Garía, E. (2003) Combination of Diclofenac plus B Vitamins in Acute Pain after Tonsillectomy: A Pilot Study. Proceedings of the Western Pharmacology Society, 46, 88-90.

[10]   Nunes, C.P., de Oliveira, P.C., de Oliveira, J.M., Mibielli, M.A., Cohen, J.C. and Nunes, F.P. (2005) A Double-Blind, Comparative, Placebo-Controlled Study in Two Arms of the Safety and Efficacy of the Anti-Inflammatory and Analgesic Action of the Association of Cyanocobalamin, Pyridoxine Chlorihydrate, Thiamine Mononitrate and Diclofenac Sodium in Tablets, in Patients with Osteoarthritis. Revista Brasileira de Medicina, 62, 486-491.

[11]   Kuhlwein, A., Meyer, H.J. and Koehler, C.O. (1990) Reduced Need for Diclofenac with Concomitant B Vitamin Therapy: Results of a Double-Blind Clinical Study with Reduced Diclofenac-Dosage (75 mg Diclofenac vs. 75 mg Diclofenac plus B Vitamins Daily) in Patients with Acute Lumbago. Klinische Wochenschrift, 68, 107-115.

[12]   Vetter, G., Brüggemann, G., Lettko, M. (1988) Verkürzung der diclofenac-therapie durch B-vinamine. Ergebnisse einer randomisierten doppelblindstudie, diclofenac 50 mg gegen diclofenac 50 mg plus B-vitamine, bei schmerzhaften wirbelsäulenerkrankungen mit degenerativen veränderungen. Zeitschrift für Rheumatologie, 47, 351-362.

[13]   Lettko, M. (1986) Ergebnisse einer Doppelblindstudie, Diclofenac und B-Vitamine gegen Diclofenac, zur Prüfung der additiven Wirksamkeit der B-Vitamine. Rheuma, Schmerz & Entzündung, 8, 22-30.

[14]   Brüggemann, G., Koehler, C.O. and Koch, E.M.W. (1990) Ergebnisse einer Doppelblindprüfung Diclofenac + Vitamin B1, B6, B12 versus Diclofenac bei Patienten mit akuten Beschwerden im Lendenwirbelsäulenbereich. Klinische Wochenschrift, 68, 116-120.